Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual

This study matches entries in ClinicalTrials.gov for cancer drug trials at initiation of the trial with later entries and with journal reports of the trials to assess modifications in trial design, external factors associated with such modifications, and transparency in reporting them.

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Autores principales: Shepshelovich, Daniel, Tibau, Ariadna, Molto, Consolación, Goldvaser, Hadar, Ocana, Alberto, Šeruga, Bostjan, Amir, Eitan
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2018
Materias:
Research Letter
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440244/
https://ncbi.nlm.nih.gov/pubmed/30520936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.5877
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares